Author:
Lassaletta A,Ramírez M,Montero J M,González-Vicent M,Balas A,Madero L,Díaz M Á
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference9 articles.
1. Valcarcel D, Martino R, Caballero D, Mateos MV, Perez-Simon JA, Canals C et al. Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant 2003; 31: 387–392.
2. Briones J, Urbano-Ispizua A, Lawler M, Rozman C, Gardiner N, Marin P et al. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells. Exp Hematol 1998; 26: 415–420.
3. Dubovsky J, Daxberger H, Fritsch G, Printz D, Peters C, Matthes S et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection. Leukemia 1999; 13: 2060–2069.
4. Diaz MA, Sevilla J, de la Rubia J, Verdeguer A, Espigado I, Vicent MG et al. Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation. Haematologica 2003; 88: 919–922.
5. Bader P, Niethammer D, Willasch A, Kreyenberg H, Klingebiel T . How and when should we monitor chimerism after allogeneic stem cell transplantation? Bone Marrow Transplant 2005; 35: 107–119.